Healius Ltd (ASX:HLS)
A$ 0.36 +0.0050 (+1.39%) Market Cap: 265.05 Mil Enterprise Value: 1.15 Bil PE Ratio: 0 PB Ratio: 0.46 GF Score: 53/100

Full Year 2025 Healius Ltd Earnings Call Transcript

Aug 21, 2025 / 01:30AM GMT
Release Date Price: A$0.7 (-13.58%)
Operator

Thank you for standing by. And welcome to the Healius Limited FY25 results. (Operator Instructions) I would like a call over to Mr. Paul Anderson, MD and CEO. Please go ahead, sir.

Paul Anderson
Healius Ltd - Chief Executive Officer, Managing Director, Director

Good morning, everyone, and welcome to our 2025 results presentation. With me today, I have our Chief Financial Officer, Steve Humphries, who you will hear from him later in the presentation. We are pleased to announce our full-year results today and provide you with additional financial information and commentary on the performance of the business this last year, our progress in relation to our T27 plans we presented back in March this year and importantly, our outlook for the year ahead.

This time last year, we set out our pathology strategy. And in March of this year, we held an Investor Day with our management team to set out specific plans on how we would deliver on this strategy.

We have now completed the sale of Lumus Imaging, repaid our debt and are cash positive as at June

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot